Loading…
On 18 September 2026 the Food Safety and Standards Authority of India (FSSAI) started three adjudication cases against Nestle India over infant nutrition products.
Two cases concern promotional claims: '5 HMOs' and 'Whey Protein' for NAN Excella Pro Stage 1, and 'easy-to-digest' whey protein for Lactogen Pro 1.
The third concerns a follow-up formula sample that fell short of the prescribed biotin (vitamin B7) content in two rounds of laboratory testing.
FSSAI cited Regulation 4(2) of the Foods for Infant Nutrition Regulations, 2020 and Section 3 of the IMS Act, 1992. Nestle India says its products and labels are compliant.
Created FSSAI and the adjudication process. Maximum penalties are ₹5 lakh for sub-standard food (Section 51), ₹3 lakh for misbranded food (Section 52) and ₹10 lakh for misleading advertisement (Section 53).
Governs claims and labelling on infant nutrition products; FSSAI says the promotional claims breached it
Prohibits advertising and promoting infant milk substitutes, feeding bottles and infant foods. Amended in 2003 to close loopholes; FSSAI cited Section 3.
Statutory food regulator under the FSS Act, 2006; functions under the Ministry of Health and Family Welfare
Hears penalty cases under the FSS Act with the powers of a civil court; appointed by the State Government
Advertising formula as matching or bettering breast milk can discourage breastfeeding. So India's IMS Act bans promotion of foods for children up to two years old, and infant-nutrition rules strictly limit the nutrition claims a label may make.
Simple Analogy: The pack may state what is inside. It may not sell itself.
GS Paper II > Statutory bodies; Health / GS Paper III > Food processing and food safety
General Awareness > Polity & Science (vitamins)
Civil penalty proceedings before an Adjudicating Officer of at least ADM rank, separate from criminal prosecution
Human milk oligosaccharides, complex sugars found in breast milk and added to some infant formulas
Vitamin B7, a water-soluble B-complex vitamin